IIT Bombay and TECCRO Sign Strategic MOU to Advance Translational Dermatology, Regenerative Medicine, and Clinical Innovation
14 October 2025
The Esthetic Clinics Clinical Research Organization (TECCRO) is pleased to announce the formal signing of a strategic Memorandum of Understanding (MOU) with the Indian Institute of Technology Bombay (IIT Bombay), one of India’s most prestigious institutions at the forefront of scientific discovery and technology development. This collaboration represents a significant step toward integrating clinical medicine with cutting-edge biomedical research and advanced engineering, with the shared goal of accelerating the future of healthcare innovation.
A Partnership Built on Complementary Strengths
This collaboration aligns the clinical excellence and translational research capabilities of TECCRO with the scientific rigor and engineering leadership of IIT Bombay. Together, both institutions aim to create a powerful platform that promotes innovation in dermatology, regenerative medicine, trichology, craniofacial reconstruction, aesthetic enhancement, and healthcare technology development.
IIT Bombay contributes extensive expertise in biomaterials, biosciences, biotechnology, bioinstrumentation, biomedical engineering, and data science. TECCRO brings deep clinical insight, regulatory experience (IRB, CDSCO, DCGI approvals), strong intellectual property leadership, multi-center clinical research capabilities, publication excellence (100+ peer-reviewed scientific articles), and real-world treatment outcomes from patient care settings at The Esthetic Clinics.
By combining scientific research systems with clinical validation pathways, the partnership ensures that discoveries do not remain confined to laboratories, but progress into viable treatments, devices, and therapeutic platforms that can meaningfully improve patient health and quality of life.
Driving Innovation Beyond Laboratory Walls
One of the core principles of this partnership is the commitment to translational research—ensuring that innovation travels the full journey from theory to real-world medical application. The focus will be on developing solutions that are patient-centered, scalable, safe, ethically sound, and globally impactful.
The collaboration will actively support:
- Joint national and international grant applications
- Co-authored, high-impact scientific publications
- Development and incubation of start-ups and IP-based ventures
- Technology transfer, product licensing, and commercialization pathways
- Access to interdisciplinary research facilities and clinical evaluation environments
This structured framework positions the collaboration to become a national model for academia–clinic innovation synergy, opening pathways for breakthrough healthcare technologies originating from India.
Key Focus Areas of the Collaboration
1. Development of Human In-Vitro Model Systems (3D Bio-Printed Skin and Hair)
The collaboration aims to establish physiologically relevant human tissue models, specifically 3D bio-printed skin and hair systems. These models will enable high-fidelity simulation of disease states, wound healing responses, pigmentation patterns, and hair growth cycles. They will support research on alopecia, regenerative aesthetics, skin repair therapies, and cosmetic dermatology.
2. Organ-on-Chip Technology for Precision Medicine
The partnership will pioneer research on Organ-on-Chip systems, where micro-engineered platforms will mimic real human biological environments. These models will allow more accurate drug screening, toxicity profiling, and therapeutic evaluation, reducing the need for animal testing and enhancing safety in early clinical development. These technologies will be essential in high precision medicine, tailoring treatments to individual biological profiles.
3. Biomedical Engineering and Translational Innovation
With access to IIT Bombay’s world-class engineering and TECCRO’s clinical implementation landscape, the collaboration will accelerate the development of diagnostic devices, non-invasive imaging systems, microfluidic tools, nano-delivery platforms, and dermatology-focused medical technologies.
4. Advancement of Stem Cell-Based Therapeutics
The partnership will expand the scientific foundation and translational readiness of stem cell-derived and cell-signaling therapies, including exosomes, biomimetic peptides, and regenerative biologics for hair and skin rejuvenation. Research will focus on optimizing safety, consistency, and therapeutic durability.
5. Strengthening High-Precision and Personalized Healthcare
By combining patient-specific clinical data with biomaterial engineering and cellular biology, the collaboration aims to enhance the development of customized treatment strategies, improving outcomes while minimizing side effects and treatment variability.
Looking Ahead
This MOU reflects a shared commitment toward building India’s leadership in globally relevant, scientifically validated, and clinically deployable healthcare innovation. By aligning research culture with clinical delivery systems, IIT Bombay and TECCRO are positioned to:
- Set new scientific and clinical standards in dermatology and regenerative research
- Strengthen India’s role in global biomedical innovation
- Create a sustainable ecosystem for clinical-grade translational science
- Support the launch of next-generation regenerative, reconstructive, and aesthetic solutions
The collaboration will now move into its operational phase, including joint project planning, shared resource access, laboratory integration meetings, and research proposal submission cycles. Both institutions anticipate that the first phase of pilot research and model system development will begin shortly.